BCM
COEPW

Basso Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Basso Capital Management’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-459,044
Closed -$15K – 82
2022
Q3 		$15K Hold
459,044
– – ﹤0.01% 257
2022
Q2 		$17K Hold
459,044
– – ﹤0.01% 475
2022
Q1 		$37K Hold
459,044
– – ﹤0.01% 501
2021
Q4 		$149K Hold
459,044
– – 0.02% 355
2021
Q3 		$119K Buy
459,044
+158,452
+53% +$60.2K 0.01% 332
2021
Q2 		$162K Hold
300,592
– – 0.02% 331
2021
Q1 		$129K Buy
300,592
+123,716
+70% +$116K 0.02% 259
2020
Q4 		$244K Buy
+176,876
New +$163K 0.06% 130

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Basso Capital Management's COEPW Position: Q4 2022 in Review

Basso Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2022, closing a stake of 459,044 shares — an estimated $15K sold.

Basso Capital Management first reported a position in COEPW in Q4 2020 and held it in 8 quarters. The position peaked at $244K in Q4 2020. 21 funds tracked by Wall St. Rank hold COEPW as of Q4 2022.

  • Basso Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 459,044 Coeptis Therapeutics Warrants shares in Q4 2022, an estimated $15K.
  • Basso Capital Management first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 8 quarters.
  • Basso Capital Management's Coeptis Therapeutics Warrants position peaked at $244K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.